<DOC>
	<DOC>NCT02895880</DOC>
	<brief_summary>The purpose of this study is to collect initial data on what survivors of childhood, adolescent, and young adult cancer think of how information about statins is communicated. Statins are medications that lower cholesterol. The results of this study will be used to improve the communication about statins. This is to aid patients and their providers in making health care decisions together, also known as shared decision making.</brief_summary>
	<brief_title>A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing</brief_title>
	<detailed_description />
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>English speaking A personal history of cancer, tumor, or a related illness Followed in the Adult Long Term Follow Up Program Received ≥ 2000 cGy radiation to the heart/chest ≥Ten years postradiation therapy to the heart/chest Age ≥ 25 years old Evidence of active progression of disease or recurrence Neurocognitive deficits that impair ability to give informed consent Current use of a statin Diagnosis of another primary cancer for which the patient is currently undergoing radiation therapy chemotherapy, or bone marrow transplant Diagnosis of CVD with or without current statin use</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Communication Tool</keyword>
	<keyword>Cancer Survivors</keyword>
	<keyword>Increase Statin</keyword>
</DOC>